MedPath

The effect of probiotics on infectious disease and DNA damage in lymphocytes of dialysis patients

Phase 3
Conditions
Chronic kidney disease.
Chronic kidney disease
Registration Number
IRCT2016103130603N1
Lead Sponsor
Shahroud University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

over 18 years of age, glomerular filtration rate less than 15 ml/min, having routine diets

Exclusion Criteria

infectious diseases, pregnancy (for female participants), autoimmune or immunosuppressive diseases, taking immunosuppressive drugs or antibiotics, lactose intolerance

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum level of endotoxin. Timepoint: Before and after the intervention (6 months). Method of measurement: Limulus Amebocyte Lysate (LAL) kit.;DNA Damage of peripheral blood mononuclear lymphocytes. Timepoint: Before and after the intervention (6 months). Method of measurement: Comet Assay.;Faecel level of endotoixn. Timepoint: Before and after the intervention (6 months). Method of measurement: Limulus Amebocyte Lysate (LAL) kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath